Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

ReNeuron and StemCells in cross-licensing deal

Executive Summary

Stem cell developer StemCells and ReNeuron Holdings PLC (stem cell research for neurological disorders) have entered into a cross-licensing agreement that gives StemCells exclusive access to ReNeuron's c-mycER adult human stem cell immortalization technology and ReNeuron exclusive access to StemCells' adult neural stem cell patents.
Deal Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • Product or Technology Swap
    • R+D and Marketing-Licensing
    • Includes Contract
    • Intra-Biotech Deal

Related Companies